Repros Theraup (NASDAQ:RPRX)
| CAPS Rating |
|
|---|
RPRX
VS S&P 500 (SPY)
RPRX News and Commentary
- Biotech Hedge Fund Bought This Surging Stock, And Other 13D/G Filings Last Week – SeekingAlpha
- 10 Stocks Favored By Hedge Funds And Company Insiders – SeekingAlpha
- 4 Highly Liquid Biotech Stocks Being Snapped Up By Insiders – SeekingAlpha
- The Strongest Small-Caps in the Market – NASDAQ
- Options Market Picks: 9 Highly Liquid Stocks with Bullish Options Sentiment – NASDAQ
- Options Market Picks: 9 Highly Liquid Stocks With Bullish Options Sentiment – The Motley Fool
- Four Biotechs to Watch Early This Week – SeekingAlpha
- Are These Stocks (Plus One ETF) Overbought and Poised to Fall? – SeekingAlpha
- Is BioSante Pharmaceuticals Next in Line to Receive Institutional Praise? – SeekingAlpha
How do you think RPRX will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
56
Outperform
42
Underperform
All-Star Players
13
Outperform
19
Underperform
Wall Street
2
Outperform
0
Underperform
RSS Headlines
Fool UK
